Solace Pharmaceuticals solacepharma.com


Public lists: Pharma Startups (4732)

Solace Pharmaceuticals research and development programs are focused on exploiting biological understanding of disease targets that play a role in the pathogenesis of pain and that have disease-modifying potential in two key areas: modulating the activity of glial cells and intervening in the tetrohydrobiopterin (BH4) pathway. SLC022, the company's lead drug candidate, is in phase II clinical development in patients with post-herpetic neuralgia (PHN).

Solace Pharmaceuticals research and development programs are focused on exploiting biological understanding of disease targets that play a role in the pathogenesis of pain and that have disease-modifying potential in two key areas: modulating the act...Show all

Company (Alive / Active)

Phone:

Fax:

222 Berkeley Street
Suite 1040
Boston, 02116
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Solace Pharmaceuticals $21.8M Mar 14, 2008
See all 20 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Solace Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors

Competitors

Company Status Description Investors

Ren Pharmaceuticals

South San Francisco, California, United States
Alive / ActiveRen Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals is interested in building collaborative research programs with academic institutions. Ren Pharmaceuticals is developing data and useful reagents (e.g. antibodies, recombinant proteins) for studying the biology of renalase. We are interested in in-licensing and developing ...Show allLogin to see details

Aegerion Pharmaceuticals

Cambridge, Massachusetts, United States
AcquiredAegerion Pharmaceuticals is a specialty pharmaceutical company. The company is focused on the development and commercialization of pharmaceuticals to treat cardiovascular and metabolic disease. Its most advanced products are MTP inhibitors which have demonstrated significant clinical effects in Phase II trials in patients with various forms of hyperlipidemia and whose cholesterol levels remain uncontrolled on currently available dyslipidemia therapies. MTP inhibitors represent a potentially new ...Show allLogin to see details
See all 20 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Aeration equipment May 14, 2013 Sep 20, 2016 Patent